Source: Contraception. Unidades: FCFRP, FMRP
Subjects: ARTERIOSCLEROSE, DISPOSITIVOS ANTICONCEPCIONAIS (COMBINAÇÃO;EFEITOS)
ABNT
STOCCO, Bianca et al. Drospirenone and levonorgestrel in combination with either 30 or 20 mcg ethinylestradiol reduce soluble adhesion molecules in Brazilian women: cross-sectional study. Contraception, v. 86, n. 5, p. 506-510, 2012Tradução . . Disponível em: https://doi.org/10.1016/j.contraception.2012.03.013. Acesso em: 19 abr. 2024.APA
Stocco, B., Fumagalli, H. F., Franceschini, S. A., Martinez, E. Z., Marzocchi-Machado, C. M., & Toloi, M. R. T. (2012). Drospirenone and levonorgestrel in combination with either 30 or 20 mcg ethinylestradiol reduce soluble adhesion molecules in Brazilian women: cross-sectional study. Contraception, 86( 5), 506-510. doi:10.1016/j.contraception.2012.03.013NLM
Stocco B, Fumagalli HF, Franceschini SA, Martinez EZ, Marzocchi-Machado CM, Toloi MRT. Drospirenone and levonorgestrel in combination with either 30 or 20 mcg ethinylestradiol reduce soluble adhesion molecules in Brazilian women: cross-sectional study [Internet]. Contraception. 2012 ; 86( 5): 506-510.[citado 2024 abr. 19 ] Available from: https://doi.org/10.1016/j.contraception.2012.03.013Vancouver
Stocco B, Fumagalli HF, Franceschini SA, Martinez EZ, Marzocchi-Machado CM, Toloi MRT. Drospirenone and levonorgestrel in combination with either 30 or 20 mcg ethinylestradiol reduce soluble adhesion molecules in Brazilian women: cross-sectional study [Internet]. Contraception. 2012 ; 86( 5): 506-510.[citado 2024 abr. 19 ] Available from: https://doi.org/10.1016/j.contraception.2012.03.013